Samlyn Capital’s Bausch Health BHC Stock Holding History

Samlyn Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-170,100	Closed	-$21.5M	–	89
2014 Q2	$21.5M	Buy	+170,100	New	+$21.7M	0.49%	71

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Samlyn Capital's BHC Position: Q3 2014 in Review

Samlyn Capital sold out of Bausch Health (BHC) in Q3 2014, closing a stake of 170,100 shares — an estimated $21.5M sold.

Samlyn Capital first reported a position in BHC in Q2 2014 and held it in 1 quarter. The position peaked at $21.5M in Q2 2014. 454 funds tracked by Wall St. Rank hold BHC as of Q3 2014.

Samlyn Capital reported no remaining Bausch Health position as of Q3 2014 after selling out during the quarter.
Samlyn Capital sold 170,100 Bausch Health shares in Q3 2014, an estimated $21.5M.
Samlyn Capital first reported a position in Bausch Health in Q2 2014 and held it in 1 quarter.
Samlyn Capital's Bausch Health position peaked at $21.5M in Q2 2014.
454 funds tracked by Wall St. Rank held Bausch Health as of Q3 2014.

Based on Samlyn Capital's 13F filing for Q3 2014, filed 14 Nov 2014.